Effects of Goji Berry Intake on Risk of Age-related Macular Degeneration: A Randomized Clinical Trial
Status: Recruiting
Location: See location...
Intervention Type: Dietary supplement
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
The goal of this project is to conduct a clinical trial in 60 participants ranging from age 65-95 who are at risk for age-related macular degeneration (AMD). The study will evaluate the effects of 14g of goji berry intake or an equivalent amount and type of fiber, five days a week for six months, on visual health, gut microbiome profiles, skin carotenoid measures, and lipoprotein profiles.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 65
Maximum Age: 95
Healthy Volunteers: t
View:
• Family history of AMD
• Hyperlipidemia or managed diabetes
• 65 - 95 years of age
Locations
United States
California
UC Davis Eye Center, Tschannen Eye Institute
RECRUITING
Sacramento
Contact Information
Primary
Denise Macias, CCRP
dcmacias@ucdavis.edu
(916) 734-6303
Time Frame
Start Date: 2024-04-29
Estimated Completion Date: 2027-06-30
Participants
Target number of participants: 60
Treatments
Experimental: Goji berry
For the goji berry arm, participants will consume goji berries.
Active_comparator: Fiber
For the fiber arm, participants will consume fiber supplements that closely matches the fiber type and amount found in the portion of goji berries.
Related Therapeutic Areas
Sponsors
Collaborators: United States Department of Agriculture (USDA)
Leads: University of California, Davis